Lido Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.85M | Buy |
35,555
+444
| +1% | +$36.6K | 0.01% | 604 |
|
|
2025
Q4 | $2.74M | Sell |
35,111
-153
| -0.4% | -$12.6K | 0.01% | 624 |
|
|
2025
Q3 | $2.74M | Buy |
35,264
+3,698
| +12% | +$289K | 0.01% | 603 |
|
|
2025
Q2 | $2.47M | Sell |
31,566
-413
| -1% | -$30.8K | 0.01% | 532 |
|
|
2025
Q1 | $2.32M | Buy |
31,979
+12,337
| +63% | +$883K | 0.01% | 508 |
|
|
2024
Q4 | $1.45M | Sell |
19,642
-462,216
| -96% | -$32.4M | 0.01% | 620 |
|
|
2024
Q3 | $13.6M | Buy |
481,858
+464,414
| +2,662% | +$33.7M | 0.07% | 160 |
|
|
2024
Q2 | $1.61M | Buy |
17,444
+1,559
| +10% | +$138K | 0.01% | 498 |
|
|
2024
Q1 | $1.52M | Sell |
15,885
-22
| -0.1% | -$1.85K | 0.01% | 509 |
|
|
2023
Q4 | $1.21M | Sell |
15,907
-54
| -0.3% | -$3.76K | 0.01% | 547 |
|
|
2023
Q3 | $1.11M | Sell |
15,961
-2,217
| -12% | -$178K | 0.01% | 514 |
|
|
2023
Q2 | $1.71M | Buy |
18,178
+1,710
| +10% | +$149K | 0.01% | 402 |
|
|
2023
Q1 | $1.36M | Buy |
16,468
+8,573
| +109% | +$674K | 0.01% | 415 |
|
|
2022
Q4 | $589K | Buy |
7,895
+484
| +7% | +$37.3K | 0.01% | 538 |
|
|
2022
Q3 | $612K | Buy |
7,411
+198
| +3% | +$19.1K | 0.01% | 496 |
|
|
2022
Q2 | $685K | Buy |
7,213
+144
| +2% | +$14.9K | 0.01% | 440 |
|
|
2022
Q1 | $832K | Sell |
7,069
-1,111
| -14% | -$125K | 0.01% | 443 |
|
|
2021
Q4 | $1.06M | Buy |
8,180
+659
| +9% | +$76.9K | 0.01% | 410 |
|
|
2021
Q3 | $851K | Buy |
7,521
+531
| +8% | +$60.6K | 0.01% | 442 |
|
|
2021
Q2 | $724K | Buy |
6,990
+1
| +0% | +$94 | 0.01% | 452 |
|
|
2021
Q1 | $585K | Buy |
6,989
+77
| +1% | +$6.51K | 0.01% | 466 |
|
|
2020
Q4 | $630K | Buy |
6,912
+363
| +6% | +$30.1K | 0.01% | 425 |
|
|
2020
Q3 | $523K | Buy |
6,549
+12
| +0.2% | +$936 | 0.01% | 367 |
|
|
2020
Q2 | $452K | Buy |
6,537
+33
| +0.5% | +$2.35K | 0.01% | 367 |
|
|
2020
Q1 | $409K | Sell |
6,504
-1,353
| -17% | -$97.6K | 0.02% | 362 |
|
|
2019
Q4 | $611K | Buy |
7,857
+2,766
| +54% | +$216K | 0.02% | 342 |
|
|
2019
Q3 | $373K | Buy |
5,091
+1,215
| +31% | +$85.3K | 0.02% | 403 |
|
|
2019
Q2 | $238K | Buy |
3,876
+18
| +0.5% | +$1.09K | 0.01% | 467 |
|
|
2019
Q1 | $246K | Buy |
+3,858
| New | +$220K | 0.02% | 438 |
|
|
2018
Q4 | – | Sell |
-4,368
| Closed | -$253K | – | 449 |
|
|
2018
Q3 | $253K | Buy |
+4,368
| New | +$214K | 0.02% | 375 |
|
|
2017
Q3 | – | Sell |
-7,215
| Closed | -$284K | – | 300 |
|
|
2017
Q2 | $284K | Sell |
7,215
-237
| -3% | -$8.65K | 0.06% | 188 |
|
|
2017
Q1 | $273K | Buy |
+7,452
| New | +$233K | 0.08% | 173 |
|
|
2016
Q3 | – | Sell |
-10,800
| Closed | -$359K | – | 167 |
|
|
2016
Q2 | $359K | Sell |
10,800
-4,200
| -28% | -$144K | 0.11% | 92 |
|
|
2016
Q1 | $441K | Buy |
+15,000
| New | +$414K | 0.15% | 64 |
|
Other funds holding EW
VCM
VPM
Lido Advisors's EW Position: Q1 2026 in Review
Lido Advisors increased its Edwards Lifesciences (EW) stake by 1.3% in Q1 2026, buying an estimated $36.6K and bringing the position to 35,555 shares worth $2.85M. The position accounts for 0.01% of the portfolio, ranked #604.
Lido Advisors first reported a position in EW in Q1 2016 and has held it in 34 quarters since. The position peaked at $13.6M in Q3 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Lido Advisors held 35,555 shares of Edwards Lifesciences worth $2.85M as of Q1 2026.
- Lido Advisors bought 444 Edwards Lifesciences shares in Q1 2026, an estimated $36.6K.
- Edwards Lifesciences made up 0.01% of Lido Advisors's portfolio in Q1 2026, its #604 holding.
- Lido Advisors first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 34 quarters since.
- Lido Advisors's Edwards Lifesciences position peaked at $13.6M in Q3 2024.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.